Export

ATC codes: N05AD01
EMLc
Indication
Schizophrenia or other primary psychotic disorders ICD11 code: 6A4Z
INN
Haloperidol
Medicine type
Chemical agent
List type
Core (EML)
Complementary (EMLc)
Formulations
Parenteral > General injections > IM: 5 mg per mL in ampoule
Oral > Liquid: 2 mg per mL (EMLc)
Oral > Solid: 2 mg ; 0.5 mg (EMLc) ; 5 mg
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Changed in 1987 (TRS 770)
Changed in 2007 (TRS 950)
Changed in 2009 (TRS 958)
Changed in 2013 (TRS 985)
Changed in 2021
Sex
All
Age
Also recommended for children
Therapeutic alternatives
Medicines within the same pharmacological class can be used
Therapeutic alternatives limitations
Therapeutic alternatives to be reviewed (2023)
Therapeutic alternatives limitations for EMLc
The square box does not apply for the listing of haloperidol on the EMLc
Patent information
Patents have expired in most jurisdictions
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Following the review of square box listings on the EML and EMLc, the Expert Committee requested the therapeutic alternatives for haloperidol on the EML be reviewed.